CTLA4 and hepatocellular carcinoma: TMA analysis confirmed these findings, demonstrating elevated CTLA4 expression but diminished GZMB levels in HBV+ CD8+ T cells compared to NBNC+HCC counterparts (Figure 3G; Figures S6C, Supporting Information).